What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to inform the public that Elevance Health (then Anthem, Inc.) executives would be meeting with securities analysts and investors. The key takeaway from these meetings was to confirm the company's ability to meet the earnings expectations previously communicated on November 14, 2001.

What are the risks mentioned in the filing that could affect Elevance Health's future results?

The filing lists several risks and uncertainties, including trends in healthcare costs and utilization, the ability to secure sufficient premium rate increases, competitor pricing, increased government regulation of health benefits and managed care, significant acquisitions or divestitures by competitors, the introduction of new prescription drugs and technology, potential downgrades in financial strength ratings, litigation targeted at health benefits companies, the ability to contract with providers, and general economic downturns.

Where can investors find more detailed information about the risks facing Elevance Health?

Investors are urged to carefully review and consider the various disclosures made by Elevance Health in its final Prospectus dated October 29, 2001, for the initial public offering, as well as in its periodic reports on Form 10-K, 10-Q, and 8-K filed with the Securities and Exchange Commission.

ELV 8-K SEC Disclosure

Q: What earnings expectations is the company confirming?

The company is confirming its ability to meet the earnings expectations that were provided in a press release and conference call on November 14, 2001. A copy of that press release was filed as Exhibit 99 to a previous Form 8-K on the same date.

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) filed a Form 8-K on January 7, 2002, to disclose information related to upcoming meetings with securities analysts and investors. The primary purpose of these meetings was to confirm the company's ability to meet previously issued earnings expectations. These expectations were initially provided in a press release and conference call on November 14, 2001. The filing serves to ensure that all material information is publicly available and to manage expectations ahead of investor discussions. The company reiterated its commitment to its prior guidance, indicating confidence in its financial performance for the period. However, the report also included standard cautionary language regarding forward-looking statements, highlighting various risks and uncertainties that could impact actual results. These include healthcare cost trends, premium rate adjustments, competitive pressures, regulatory changes, and economic conditions. Investors are advised to consider these risks when evaluating the company's future prospects.

Key Highlights

1Confirmation of ability to meet previously issued earnings expectations.
2Discussions with securities analysts and investors scheduled for the week of January 7, 2002.
3Reiteration of earnings guidance provided in a November 14, 2001 press release and conference call.
4Inclusion of cautionary language regarding forward-looking statements.
5Identification of key risks and uncertainties that could affect financial results.
6Emphasis on the need for investors to review detailed disclosures in SEC filings.

Elevance Health, Inc. 8-K Report (Jan 7, 2002)

Summary

Key Highlights

Frequently Asked Questions